Igc Pharma Inc
(IGC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,539 | -1,882 | -7,315 | -4,161 | -2,558 |
| Depreciation Amortization | 185 | 77 | 144 | 69 | 45 |
| Accounts receivable | -134 | -157 | -49 | -73 | -160 |
| Accounts payable and accrued liabilities | 239 | 377 | 442 | 278 | 555 |
| Other Working Capital | -3,461 | -2,349 | -3,058 | -3,116 | -2,292 |
| Other Operating Activity | 260 | -54 | 1,159 | 319 | -34 |
| Operating Cash Flow | $-6,450 | $-3,988 | $-8,677 | $-6,684 | $-4,444 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 1,231 | -17 | -5,081 | -5,063 | -5,039 |
| PPE Investments | -1,229 | -944 | -4,389 | -3,675 | -2,049 |
| Purchase Of Investment | -149 | -149 | N/A | 0 | 0 |
| Purchase Sale Intangibles | -48 | -26 | -77 | -68 | -23 |
| Other Investing Activity | -48 | -26 | -77 | -68 | -23 |
| Investing Cash Flow | $-195 | $-1,136 | $-9,547 | $-8,806 | $-7,111 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 530 | 580 | N/A | N/A | N/A |
| Common Stock Issued | N/A | N/A | -59 | 18 | 18 |
| Financing Cash Flow | $530 | $580 | $-59 | $18 | $18 |
| Exchange Rate Effect | 8 | -11 | -69 | -9 | -10 |
| Beginning Cash Position | 7,258 | 7,258 | 25,610 | 25,610 | 25,610 |
| End Cash Position | 1,151 | 2,703 | 7,258 | 10,129 | 14,063 |
| Net Cash Flow | $-6,107 | $-4,555 | $-18,352 | $-15,481 | $-11,547 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,450 | -3,988 | -8,677 | -6,684 | -4,444 |
| Capital Expenditure | -1,229 | -944 | -4,389 | -3,675 | -2,049 |
| Free Cash Flow | -7,679 | -4,932 | -13,066 | -10,359 | -6,493 |